HESTA
Inventia Snags $3.2M in New Funding to Commercialize Bioprinter
After announcing a Series B round last January, Sydney-headquartered biotech startup Inventia received an additional AU$4.4 million ($3.2 million) from Australian pension fund giant HESTA. This latest investment brings Inventia’s…